Tag Archive: Confidential Business Information

Uganda – GMO Legislation

OVERVIEW

INTRODUCTION

During 2001, Uganda embarked on a national agricultural biotechnology programme focusing on the several transformative biotechnology innovations, and genetic engineering (GE). This programme is linked to Uganda?s policy to eradicate poverty by 2015, described in its Poverty Eradication Action Plan (PEAP). PEAP is Uganda?s overarching macro-economic framework, designed to transform Uganda into a modern economy. PEAP has been developed within the context already established by structural adjustment policies put in place in Uganda since 1987, which has led inter alia, to the liberalisation of the seed production and supply sector. The opening of the seed industry has resulted in the influx of foreign seed companies that supply hybrid seed to farmers.

PEAP sets out two groups of actions, which it sees as directly increasing the ability of the poor to raise their incomes and improve their quality of life: (1) the radical transformation of rural communities from subsistence farming to commercial agriculture; and (2) a Plan for the modernization of Agriculture (PAM). The uptake of GE is an integral part of PAM.?

During 2003, the National Council for Science and Technology developed a National Policy on Biotechnology and Biosafety (PBB) wherein it describes a

Bt-Maize GA21 / Syngenta

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB)

ObjectionsSyngentaGA21.pdf Objections To The Application Made By Syngenta Seedco In Respect Of Event Ga21 To The National Department Of Agriculture, South Africa
Mariam Mayet and Shenaz Moola, 13 September 2004

read more
OVERVIEW
SCIENTIFIC OBJECTIONS

A scientific assessment was made of the available information. The main findings are:

  • A full assessment of the scientific data could not be made because of the designation of sections of the application as Confidential Business Information
  • Genetic modification by the application of recombinant DNA technology is characterised by scientific uncertainty. This stems from several factors including the inherent imprecision of currently employed recombinant DNA techniques, the use of powerful promoter sequences in genetic constructs and the generation, as a result of genetic modification, of novel proteins to which humans and animals have never previously been exposed
  • The molecular characterisation information provided by the notifier indicates several irregularities including open reading frames and a truncated constructs which could give rise to unintended gene effects
  • The transfer of the herbicide-tolerant trait to weeds could result in increased herbicide application. The potential for economically important weeds developing herbicide tolerance is a cause for concern
  • Glyphosate use

BT-Maize MON863 and MON863 X MON810 / Monsanto

SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB)
  • Objections to the Application Made by Monsanto South Africa for a Commodity Import Permit of Grain for Feed and Food Purposes that may Contain Maize Grains Derived From Insect-Protected Maize Line Mon863 and Maize Hybrids Mon863 X Mon810
    Mariam Mayet and Shenaz Moola, August 2004
read more
  • CoverLetter_Mon830X810.pdf Cover Letter to the Registrar
    August 2004
read more
OVERVIEW
SCIENTIFIC OBJECTIONS

A scientific assessment was made of the available information. The main findings of this assessment, which are discussed in greater detail later in the document, are:

  • A full assessment of the scientific data could not be made because of the designation of large sections of this data as Confidential Business Information
  • The molecular characterisation information provided by the notifier indicates several irregularities including open reading frames, a missing stop codon and truncated constructs which could give rise to unintended gene effects
  • There is evidence of structural instability arising out of the use of the 35S CaMV promoter and there is a call for the discontinuation of the use of this genetic element in the development of transgenic plants
  • The protocols for assessing gene expression in transgenic plants are